RedHill Biopharma Ltd (RDHL)

[DorseyE]

SEEKING ALPHA
Article about RDHL
Summary

RedHill has a stable line of approved, marketed and pipeline products.
Its cash balance is a little low.
The company looks interesting for a long-term, low risk appetite investor.
RedHill Biopharma (RDHL) is an evolving specialty biopharma based out of Israel, with offices in the US. In earlier years, this small company was almost exclusively a promoter of other people’s legacy products - so it promoted and sold a number of low-grade products like Donnatal, Mystesi, EnteraGam and so on. Starting out in 2017, it used its sales force in the US to promote these products, made very little money, and discontinued the practice last year. However, it must have been a good learning experience for management and the sales team, making them ready for what was to come.